<DOC>
	<DOCNO>NCT01344863</DOCNO>
	<brief_summary>This randomize , open-label , parallel , 2-arm , multicenter study compare administration Herceptin ( trastuzumab ) single-use injection device versus handheld syringe healthy male volunteer . The volunteer receive single dose 600 mg Herceptin . The anticipated time study 21 week .</brief_summary>
	<brief_title>A Study Administration Trastuzumab ( Herceptin ) Single-use Injection Device Versus Handheld Syringe</brief_title>
	<detailed_description />
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Healthy male patient , 18 45 year age , inclusive No history hypersensitivity allergic reaction follow drug administration No history clinically significant clinically relevant cardiac condition No history previous anticancer treatment Body mass index ( BMI ) 1832 kg/m2 , inclusive Positive test result drug abuse Positive test result hepatitis B , hepatitis C , HIV 1 2 Systolic blood pressure great 140 mmHG less 90 mmHG , diastolic blood pressure great 90 mmHG less 50 mmHG Clinically significant abnormal laboratory value</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>